Study to Evaluate the Safety & Tolerability of MRT5005 Administered by Nebulization in Adults With Cystic Fibrosis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This Phase 1/2, first-in-human study will evaluate the safety and tolerability of single and multiple escalating doses of MRT5005 administered by nebulization to the respiratory tract of adult subjects with CF.
Epistemonikos ID: b46dccdeff6d6c623beb33316c327d297966fa14
First added on: May 21, 2024